ArticleHuman vaccines & immunotherapeutics2017

Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.

Juliana L Meyers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.